Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene®) in healthy adults-Reference-Cited by-同舟云学术

Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene®) in healthy adults

Published:2006-06 Issue:25 Volume:24 Page:5320-5326
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Rebedea I.,Diaconescu I.G.,Bach D.,Bartelsen O.,Arndtz N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference17 articles.

1. World Health Organization, fact sheet no. 204: hepatitis B. Revised October 2000. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/index.html [accessed 18 May 2005].

2. Progress towards the comprehensive control of hepatitis B. Introduction;Zuckerman;Gut,1996

3. Hepatitis B: a serious public health threat. Viral Hepatitis Prevention Board;Grob;Vaccine,1998

4. Recombinant hepatitis B vaccines: disease characterization and vaccine production;Brocke,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a new vaccine at the laboratory scale;Bioreactor Design Concepts for Viral Vaccine Production;2024

2. Platforms, advances, and technical challenges in virus-like particles-based vaccines;Frontiers in Immunology;2023-02-09

3. Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic;International Journal of Pharmaceutics;2021-12

4. Recent Progress on the Versatility of Virus-Like Particles;Vaccines;2020-03-20

5. Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China;Pediatric Infectious Disease Journal;2017-01